TAXUS¿ ELEMENT¿ LONG
Report
- Report Number
- 2134265-2013-00639
- Event Type
- Injury
- Date Received
- February 14, 2013
- Date of Event
- November 27, 2012
- Report Date
- January 18, 2013
- Manufacturer
- BOSTON SCIENTIFIC - GALWAY
- Product Code
- NIQ
- PMA / PMN Number
- P100023
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- SP
- Reporter Occupation
- PHYSICIAN
Narratives
PATIENT IDENTIFIER: (B)(6). DEVICE IS A COMBINATION PRODUCT. DEVICE EVALUATED BY MFR: IT IS INDICATED THAT THE DEVICE WILL NOT BE RETURNED FOR EVALUATION; THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. THE MANUFACTURING BATCH RECORD REVIEW CONFORMED THAT THE DEVICE MET ALL MATERIAL, ASSEMBLY AND PERFORMANCE SPECIFICATIONS. THE MOST PROBABLE ROOT CAUSE IS ANTICIPATED PROCEDURAL COMPLICATION AS THE REPORTED EVENT IS DUE TO A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE NOTED WITHIN THE PRODUCT DIRECTIONS FOR USE (DFU) AND/OR DEVICE LABELING. (B)(4).
(B)(4) STUDY. SAME CASE AS MDR ID#: 2134265-2013-00638. IT WAS REPORTED THAT FOLLOWING A CORONARY ARTERY STENTING TREATMENT PROCEDURE, THE PATIENT IN-STENT RESTENOSIS AND REQUIRED A TARGET VESSEL REVASCULARIZATION (TVR). IN (B)(6) 2011, THE PATIENT PRESENTED DUE TO UNSTABLE ANGINA (BRAUNWALD CLASSIFICATION IIIB) AND WAS REFERRED FOR CARDIAC CATHETERIZATION. THE 1ST DE NOVO TARGET LESION WAS A LONG LESION LOCATED IN THE MID RIGHT CORONARY ARTERY (MID RCA) WITH 70% STENOSIS AND WAS 20MM LONG WITH A REFERENCE VESSEL DIAMETER OF 2.80MM. THE PHYSICIAN TREATED THE LESION WITH PRE-DILATION AND PLACEMENT OF A 3.00X38MM TAXUS ELEMENT STENT, WITH 0% RESIDUAL STENOSIS FOLLOWING POST-DILATION. THE 2ND DE NOVO TARGET LESION WAS A LONG LESION LOCATED IN THE MID RIGHT CORONARY ARTERY (MID RCA) WITH 70% STENOSIS AND WAS 23MM LONG WITH A REFERENCE VESSEL DIAMETER OF 3.4MM. THE PHYSICIAN TREATED THE LESION WITH PRE-DILATION AND PLACEMENT OF A 3.50X38MM TAXUS ELEMENT STENT, WITH 0% RESIDUAL STENOSIS FOLLOWING POST-DILATION. THE PATIENT WAS DISCHARGED ON ASPIRIN AND CLOPIDOGREL. IN (B)(6) 2012, THE PATIENT WAS HOSPITALIZED AND REFERRED FOR CARDIAC CATHETERIZATION. CORONARY ANGIOGRAPHY REVEALED 70% FOCAL RESTENOSIS OF THE PREVIOUSLY PLACED STUDY STENT IN THE MID RCA, WHICH WAS TREATED WITH BALLOON ANGIOPLASTY, WITH 0% RESIDUAL STENOSIS. THE EVENT WAS CONSIDERED AS RESOLVED WITHOUT RESIDUAL EFFECTS AND THE PATIENT WAS DISCHARGED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 65253 | TAXUS¿ ELEMENT¿ LONG | CORONARY DRUG-ELUTING STENT | NIQ | BOSTON SCIENTIFIC - GALWAY | H7493902538350 | 13379949 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 61 YR | Hospitalization| R |